# Norspan Transdermal Patches Study in Osteoarthritis Patients

> **NCT01643759** · PHASE1 · COMPLETED · sponsor: **Mundipharma (China) Pharmaceutical Co. Ltd** · enrollment: 30 (actual)

## Conditions studied

- Osteoarthritis Disorders

## Interventions

- **DRUG:** buprenorphine

## Key facts

- **NCT ID:** NCT01643759
- **Lead sponsor:** Mundipharma (China) Pharmaceutical Co. Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-07
- **Primary completion:** 2010-03
- **Final completion:** —
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2015-07-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01643759

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01643759, "Norspan Transdermal Patches Study in Osteoarthritis Patients". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01643759. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*